iDCL Trial Research Group. Predictors of Time-in-Range (70–180 mg/dL) Achieved Using a Closed-Loop Control System - Schoelwer, MJ; Kanapka, LG; Wadwa, RP (Diabetes Technol Ther, 2021)
et al.